11.05.2015 • NewsDede WillamsDow ChemicalExxonMobil

Dow Completes Buyout of ExxonMobil’s Univation Stake

Dow Chemical has acquired ExxonMobil Chemical's share of US technology licensor Univation Technologies for an undisclosed sum. The deal was announced in October 2014.

Previously a 50:50 joint venture of the two US groups, Univation licenses the widely used Unipol polyethylene process and also is a leading manufacturer of catalysts for the process, which permits plant operators to swing between production of linear low density and high density PE grades.

The technology firm also develops and supplies catalysts, including UCAT Conventional, Acclaim Advanced Unimodal, XCAT metallocene and Prodigy bimodal catalysts.

Dow said the purchase of its partner's stake reflects its strategic focus on investing in businesses with strong competitive positions in attractive markets.

Univation Technologies will operate in future as a wholly-owned subsidiary of Dow, led by its president, Steve Stanley, and will continue to be based in Houston, Texas.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.